DENVER and VANCOUVER, British Columbia, April 04, 2023 (GLOBE NEWSWIRE) -- Koios Beverage Corp. (CSE: FIT; OTC: FITSF) (the "Company" or "Koios") is pleased to announce a non-brokered private placement of up to 33,451,619 units ("Units") at a price of CAD $0.05 per Unit for gross aggregate proceeds of up to $1,672,580.95 (the "Offering").
Each Unit consists of one common share in the capital of the Company (each, a "Share") and one transferable common share purchase warrant (each, a "Warrant"), each Warrant entitles the holder to acquire one additional Common Share of the Company at a price of $0.05 for a period of 24 months from the date of issuance.
Closing of the proposed Offering is anticipated to occur on or about April 13, 2023. The Company does not anticipate paying any finder's fees in connection with the Offering. The Company intends to use the aggregate net proceeds of the Offering for the purchase of printed beverage cans, inventory management software, the purchase of raw ingredients/materials, leasehold improvements, inventory management, marketing, research and development and for general administrative and working capital expenses including salaries, wages and professional fees.
All securities issued pursuant to the Offering will be to a statutory hold period of four months and one day from the date of issuance in accordance with applicable securities laws of Canada.
MI 61-101 Disclosure
Certain insiders of the Company will be participating in the Offering for an aggregate total of 10,710,500 Units. The participation by such insiders is considered a "related-party transaction" within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transaction ("MI 61-101"). The Company will rely on exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) of MI 61-101 in respect of related party participation in the Offering as neither the fair market value (as determined under MI 64-101) of the subject matter of, nor the fair market value of the consideration for, the transaction, insofar as it involved the related parties, exceeded 25% of the Company's market capitalization (as determined under MI 61-101).
None of the securities issued in connection with the Offering have been registered under the United States Securities Act of 1933, as amended (the "1933 Act"), and none of them have been offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This news release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of the securities in any state where such offer, solicitation, or sale would be unlawful.
On behalf of the Board of Directors of the Company,
KOIOS BEVERAGE CORP.
"Chris Miller"
Chris Miller, CEO, and Director
For further information, please contact:
Gina Burrus
844-255-6467
gina@koiosbeveragecorp.com
THE CANADIAN SECURITIES EXCHANGE (CSE) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
About Koios Beverage Corp.
The Company is an emerging functional beverage company which has an available distribution network of more than 4,400 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products have been shown to enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain.
Koios produces one of the only drinks in the world infused with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website: .
Forward-Looking Statements
This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information in this news release includes statements regarding: Statements pertaining to the use of proceeds and the closing of the Offering. The forward-looking information reflects management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the functional beverage markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company's management to predict all risk factors, nor can the Company assess the impact of all factors on Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law.
This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by Koios with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with Koios is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.
不列顛哥倫比亞省丹佛和溫哥華,2023年4月4日(環球通訊社)Koios Beverage Corp.(CSE:FIT;OTC:FITSF)(“公司”或“Koios”)欣然宣佈以非經紀方式配售最多33,451,619個單位(“單位“)總收益不超過1,672,580.95美元的價格為每單位0.05加元(”供奉“)。
每個單位由公司股本中的一股普通股組成(每股,一股分享)及一份可轉讓普通股認購權證(每份搜查令“),每份認股權證持有人有權以0.05元的價格購入額外一股本公司普通股,為期24個月,由發行日期起計。
擬議中的IPO預計將於2023年4月13日左右完成。該公司預計不會支付與此次發行相關的任何尋找者費用。該公司打算將發售所得淨額用於購買印刷飲料罐、庫存管理軟體、購買原材料/材料、改善租賃、庫存管理、營銷、研究和開發,以及用於一般行政和營運資本支出,包括工資、工資和專業費用。
根據加拿大適用的證券法,根據此次發行發行的所有證券的法定持有期為自發行之日起四個月零一天。
MI61-101披露
該公司的某些內部人士將參與發售,總計發售10,710,500個單位。這種內部人士的參與被認為是多邊文書61-101--特別交易中保護少數群體擔保持有人(“MI 61-101”)所指的“關聯方交易”。本公司將依據MI 61-101第5.5(A)節所載有關關聯方參與發售的MI61-101正式估值及小股東批准規定的豁免,因為涉及關聯方的交易標的的公平市價(根據MI 64-101釐定)或代價的公平市價均不超過本公司市值(根據MI 61-101釐定)的25%。
與此次發行相關發行的證券均未根據修訂後的《1933年美國證券法》(下稱《1933年法案》)進行註冊,也未在未進行註冊或未獲得1933年法案註冊要求的適用豁免的情況下在美國發行或出售。本新聞稿不應構成出售要約或邀請購買要約,也不應在任何這樣的要約、招攬或出售將是非法的任何州出售證券。
我謹代表公司董事會:
肯德基飲料公司。
《克裡斯·米勒》
首席執行官克裡斯·米勒和董事
如需更多資訊,請聯繫:
吉娜·伯勒斯
844-255-6467
郵箱:gia@koiosDrinaagecorp.com
加拿大證券交易所(CSE)沒有對本新聞稿的準確性或充分性進行審查,也不承擔任何責任。
Koios Beverage Corp.簡介
該公司是一家新興的功能飲料公司,在美國各地擁有4400多個零售地點的分銷網路,在這些地點銷售其產品。Koios與美國一些最大和最負盛名的分銷商建立了關係,其中包括Europa Sports、肌肉食品美國公司、KeHE和Wish-U-Well。Koios使用專利的促進劑和天然有機化合物的混合物來提高人類的生產力,而不使用有害的化學品或興奮劑。Koios產品已被證明可以增強注意力、注意力、思維能力、記憶力、認知功能、警覺性和大腦能力,並創造全天的精神清晰度。它的成分是專門設計的,通過增加大腦中的血液流量、氧氣水準和神經連接來靶向大腦功能。
Koios生產的飲料是世界上僅有的注入MCT油的飲料之一。MCT油來自椰子,已被證明有助於身體更有效地燃燒脂肪,從天然食物來源創造持久的能量,在大腦中產生酮,允許更好的大腦功能和清晰度,支持健康的荷爾蒙分泌和提高免疫力。欲瞭解更多資訊,請訪問我們的網站:。
前瞻性陳述
本新聞稿包含適用於加拿大證券法的“前瞻性資訊”。前瞻性資訊和資訊常常但不總是可以通過使用諸如“計劃”、“預期”或“不預期”、“預期”、“估計”、“打算”、“預期”或“不預期”或“相信”等詞語或這些詞語和短語的變體來確定,或說明“可能”、“可能”、“將”、“可能”或“將”採取、發生或實現某些行動、事件或結果。本新聞稿中的前瞻性資訊包括有關以下方面的陳述:與收益的使用和發售結束有關的陳述。前瞻性資訊反映了管理層基於現有資訊的當前預期,可能會受到一些風險和不確定因素的影響,這些風險和不確定因素可能導致結果與前瞻性資訊中討論的結果大不相同。儘管公司認為編制前瞻性資訊時使用的假設和因素是合理的,但不應過度依賴這些資訊,也不能保證此類事件將在披露的時間框架內發生或根本不會發生。可能導致實際結果或事件與當前預期大不相同的因素包括:(I)不利的市場狀況;(Ii)功能飲料市場的增長和規模的變化;以及(Iii)公司無法控制的其他因素。該公司在一個快速發展的環境中運營。新的風險因素不時出現,公司管理層不可能預測所有風險因素,也無法評估所有因素對公司業務的影響,或任何因素或因素組合可能導致實際結果與任何前瞻性資訊中包含的結果不同的程度。本新聞稿中包含的前瞻性資訊是截至本新聞稿發佈之日的資訊,除適用法律要求外,公司明確表示不會因新資訊、未來事件或其他原因而更新或修改任何前瞻性資訊,也不承擔任何義務。
本新聞稿可能包含第三方實體(或其各自產品的商標名稱)的商標名稱,通常指的是(I)Koios與本新聞稿中提及的此類第三方實體之間的關係和/或(Ii)本新聞稿中提及其與Koios的關係的客戶/供應商/服務提供商。這些商標的所有權利由其各自的所有者或被許可人保留。